JO
VERA icon

John Overdeck’s Vera Therapeutics VERA Stock Holding History

John Overdeck’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.47M Sell
104,170
-105,981
-50% -$3.95M ﹤0.01% 2247
2026
Q1 		$8.45M Buy
210,151
+200
+0.1% +$8.62K 0.01% 1529
2025
Q4 		$10.6M Buy
209,951
+38,292
+22% +$1.36M 0.02% 1081
2025
Q3 		$4.99M Buy
171,659
+42,524
+33% +$983K 0.01% 1464
2025
Q2 		$3.04M Buy
129,135
+119,584
+1,252% +$2.69M 0.01% 1550
2025
Q1 		$229K Sell
9,551
-31,900
-77% -$1.03M ﹤0.01% 2813
2024
Q4 		$1.75M Sell
41,451
-7,102
-15% -$314K ﹤0.01% 1806
2024
Q3 		$2.15M Sell
48,553
-108,928
-69% -$4.13M ﹤0.01% 1635
2024
Q2 		$5.7M Buy
157,481
+16,131
+11% +$640K 0.01% 951
2024
Q1 		$6.1M Buy
141,350
+40,058
+40% +$1.43M 0.01% 877
2023
Q4 		$1.56M Buy
101,292
+731
+0.7% +$9.28K ﹤0.01% 1784
2023
Q3 		$1.38M Buy
100,561
+67,361
+203% +$1.16M ﹤0.01% 1735
2023
Q2 		$533K Sell
33,200
-13,814
-29% -$125K ﹤0.01% 2299
2023
Q1 		$365K Buy
47,014
+29,997
+176% +$232K ﹤0.01% 2340
2022
Q4 		$329K Buy
+17,017
New +$308K ﹤0.01% 2210

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

John Overdeck's VERA Position: Q2 2026 in Review

John Overdeck reduced its Vera Therapeutics (VERA) stake by 50% in Q2 2026, selling an estimated $3.95M and leaving 104,170 shares worth $4.47M. The position accounts for ﹤0.01% of the portfolio, ranked #2247.

John Overdeck first reported a position in VERA in Q4 2022 and has held it in 15 quarters since. The position peaked at $10.6M in Q4 2025. 218 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • John Overdeck held 104,170 shares of Vera Therapeutics worth $4.47M as of Q2 2026.
  • John Overdeck sold 105,981 Vera Therapeutics shares in Q2 2026, an estimated $3.95M.
  • Vera Therapeutics made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2247 holding.
  • John Overdeck first reported a position in Vera Therapeutics in Q4 2022 and has held it in 15 quarters since.
  • John Overdeck's Vera Therapeutics position peaked at $10.6M in Q4 2025.
  • 218 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.